Verified ComparisonLast updated: 7 April 2026
P21 vs Cerebrolysin
P21 (cell-cycle inhibitor peptide) regulates senescence pathways. Cerebrolysin is a peptide mixture from brain tissue with neuroprotective effects.
P21
Cognitive
3.9/ 5
B+
Cerebrolysin
Cognitive
4.0/ 5
B+
Editor's note
P21 targets senescence; Cerebrolysin targets neurodegeneration. Different mechanisms.
| Criterion | P21 | Cerebrolysin |
|---|---|---|
| Source/composition | Synthetic senescence inhibitor | Brain-derived peptide mixture |
| Primary target | Cell-cycle arrest/senescence | Neurodegeneration |
| Mechanism specificity | High (p21 pathway) | Broad (multiple neuropath) |
| Clinical trial data | Emerging | Multiple trials (stroke, dementia) |
| Research focus geography | US/EU | EU/Russia |
Frequently asked questions
Cerebrolysin has more clinical trials; P21 is newer with emerging mechanistic data.
Want to read the full reviews?